NCT00165035View on ClinicalTrials.gov

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,701

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

July 31, 2011

Conditions
Coronary Disease
Interventions
DEVICE

CoStar Paclitaxel Drug Eluting Coronary Stent System

Drug eluting stent

DEVICE

TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent

Drug eluting stent

Trial Locations (2)

27705

Duke University Medical Center, Durham

45219

Christ Linder, Cincinnati

Sponsors

Lead Sponsor

Cordis Corporation

Collaborators (1)

Conor Medsystems
All Listed Sponsors
collaborator

Conor Medsystems

INDUSTRY

lead

Cordis Corporation

INDUSTRY

NCT00165035 - Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II) | Biotech Hunter | Biotech Hunter